Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-100052
Filing Date
2024-09-16
Accepted
2024-09-16 10:22:56
Documents
3
Group Members
HEIGHTS CAPITAL MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2424070d1_sc13g.htm SC 13G 61168
2 EXHIBIT I tm2424070d1_ex99-i.htm EX-99.I 5012
3 EXHIBIT II tm2424070d1_ex99-ii.htm EX-99.II 4190
  Complete submission text file 0001104659-24-100052.txt   72133
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Subject) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: SC 13G | Act: 34 | File No.: 005-92289 | Film No.: 241299896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8080
CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings)

EIN.: 981253664 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G